Redeye provides a research update following the Q3 report published by Initiator Pharma earlier toda...
Bid of DKK 16.5/share is a ~110% premium to last close Several major shareholders intend to accept t...
Redeye shares its initial comments on Ngenic’s Q3 report, published this morning.
Solwers posted Q3 results that were on the weak side on profitability versus Q3 2023.
Redeye updates its estimates following MindArk’s weaker-than-expected Q3 report.
Redeye endorses Mentice appointing Frans Venker as its new CEO (effective 01 January 2025), some six...
Redeye gives initial comments on the acquisition by Tagmaster that was announced today.
Zoomability Int AB (”Zoomability” eller ”bolaget”) publicerade den 28 november 2024 bolagets delårsr...
En utmanande solmarknad tillsammans med en svag byggkonjunktur har påverkat bolagets nettoomsättning...
Lipigons fas 2a-studie med triglyceridsänkaren Lipisense har inkluderat sin första patient, en vikti...
Redeye comments on Verve Group’s Q3 2024 results, which exceeded expectations in terms of sales.
Endomines released a profit warning due to lower-than-expected production volume growth in Q4 driven...
Prolight continues to make progress with its proprietary Psyros platform, with a pre-validation stud...
Redeye has revised its forecast following TH1NG’s Q3 2024 report, where sales declined y/y due to th...
MoveByBike Europe AB (”MoveByBike” eller ”Bolaget”) publicerade den 26 november 2024 Bolagets kvarta...
